Skip to main content
Top
Published in: BMC Cancer 1/2009

Open Access 01-12-2009 | Research article

Validation of a prognostic scoring system for locally recurrent nasopharyngeal carcinoma treated by stereotactic radiosurgery

Authors: Daniel TT Chua, Kwan-Ngai Hung, Victor Lee, Sherry CY Ng, Janice Tsang

Published in: BMC Cancer | Issue 1/2009

Login to get access

Abstract

Background

Selection of patients with local failure of nasopharyngeal carcinoma (NPC) for appropriate type of salvage treatment can be difficult due to the lack of data on comparative efficacy of different salvage treatments. The purpose of the present study was to validate a previously published prognostic scoring system for local failures of NPC treated by radiosurgery based on reported results in the literature.

Methods

A literature search yielded 3 published reports on the use of radiosurgery as salvage treatment of NPC that contained sufficient clinical information for validation of the scoring system. Prognostic scores of 18 patients from these reports were calculated and actuarial survival rates were estimated and compared to the original cohort used to design the prognostic scoring system. The area under the receiver operating characteristic curve was also determined and compared between the current and original patient groups.

Results

The calculated prognostic scores ranged from 0.32 to 1.21, with 15 patients assigned to the poor prognostic group and 3 to the intermediate prognostic group. The actuarial 3-year survival rates in the intermediate and poor prognostic groups were 67% and 0%, respectively. These results were comparable to the observed 3-year survival rates of 74% and 23% in the intermediate and poor prognostic group in the original reports. The area under the receiver operating characteristic curve for the current patient group was 0.846 which was similar to 0.841 in the original group.

Conclusion

The previously published prognostic scoring system demonstrated good prediction of treatment outcome after radiosurgery in a small group of NPC patients with poor prognosis. Prospective study to validate the scoring system is currently being carried out in our institution.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lee AW, Sze WM, Au JS, et al: Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2005, 61: 1107-1116.CrossRefPubMed Lee AW, Sze WM, Au JS, et al: Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2005, 61: 1107-1116.CrossRefPubMed
2.
go back to reference Leung TW, Tung SY, Sze WK, Wong FC, Yuen KK, Lui CM, Lo SH, Ng TY, O SK: Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patterns. Head Neck. 2005, 27: 555-565. 10.1002/hed.20189.CrossRefPubMed Leung TW, Tung SY, Sze WK, Wong FC, Yuen KK, Lui CM, Lo SH, Ng TY, O SK: Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patterns. Head Neck. 2005, 27: 555-565. 10.1002/hed.20189.CrossRefPubMed
3.
go back to reference Wei WI: Salvage surgery for recurrent primary nasopharyngeal carcinoma. Crit Rev Oncol Hemat. 2000, 33: 91-98. 10.1016/S1040-8428(99)00069-4.CrossRef Wei WI: Salvage surgery for recurrent primary nasopharyngeal carcinoma. Crit Rev Oncol Hemat. 2000, 33: 91-98. 10.1016/S1040-8428(99)00069-4.CrossRef
4.
go back to reference Choy D, Sham JS, Wei WI, Ho CM, Wu PM: Transpalatal insertion of radioactive gold grain for the treatment of persistent and recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 1993, 25: 505-512.CrossRefPubMed Choy D, Sham JS, Wei WI, Ho CM, Wu PM: Transpalatal insertion of radioactive gold grain for the treatment of persistent and recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 1993, 25: 505-512.CrossRefPubMed
5.
go back to reference Leung TW, Tung SY, Sze WK, Sze WM, Wong VY, O SK: Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2000, 47: 405-412. 10.1016/S0360-3016(00)00463-6.CrossRefPubMed Leung TW, Tung SY, Sze WK, Sze WM, Wong VY, O SK: Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2000, 47: 405-412. 10.1016/S0360-3016(00)00463-6.CrossRefPubMed
6.
go back to reference Lee AW, Foo W, Law SC, Poon YF, Sze WM, O SK, Tung SY, Lau WH: Reirradiation for recurrent nasopharyngeal carcinoma: factors affecting the therapeutic ratio and ways for improvement. Int J Radiat Oncol Biol Phys. 1997, 38: 43-52.CrossRefPubMed Lee AW, Foo W, Law SC, Poon YF, Sze WM, O SK, Tung SY, Lau WH: Reirradiation for recurrent nasopharyngeal carcinoma: factors affecting the therapeutic ratio and ways for improvement. Int J Radiat Oncol Biol Phys. 1997, 38: 43-52.CrossRefPubMed
7.
go back to reference Chua DT, Sham JS, Kwong DL, Wei WI, Au GK, Choy D: Locally recurrent nasopharyngeal carcinoma: treatment results for patients with computed tomography assessment. Int J Radiat Oncol Biol Phys. 1998, 41: 379-386.CrossRefPubMed Chua DT, Sham JS, Kwong DL, Wei WI, Au GK, Choy D: Locally recurrent nasopharyngeal carcinoma: treatment results for patients with computed tomography assessment. Int J Radiat Oncol Biol Phys. 1998, 41: 379-386.CrossRefPubMed
8.
go back to reference Chua DT, Sham JS, Leung LH, Au KH: Reirradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy. Radiother Oncol. 2005, 77: 290-294. 10.1016/j.radonc.2005.10.010.CrossRefPubMed Chua DT, Sham JS, Leung LH, Au KH: Reirradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy. Radiother Oncol. 2005, 77: 290-294. 10.1016/j.radonc.2005.10.010.CrossRefPubMed
9.
go back to reference Cmelak AJ, Cox RS, Adler JR, Fee WE, Goffinet DR: Radiosurgery for skull base malignancies and nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 1997, 37: 997-1003.CrossRefPubMed Cmelak AJ, Cox RS, Adler JR, Fee WE, Goffinet DR: Radiosurgery for skull base malignancies and nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 1997, 37: 997-1003.CrossRefPubMed
10.
go back to reference Buatti JM, Friedman WA, Bova FJ, Mendenhall WM: Linac radiosurgery for locally recurrent nasopharyngeal carcinoma: rationale and technique. Head Neck. 1995, 17: 14-19. 10.1002/hed.2880170104.CrossRefPubMed Buatti JM, Friedman WA, Bova FJ, Mendenhall WM: Linac radiosurgery for locally recurrent nasopharyngeal carcinoma: rationale and technique. Head Neck. 1995, 17: 14-19. 10.1002/hed.2880170104.CrossRefPubMed
11.
go back to reference Chua DT, Sham JS, Hung KN, Kwong DL, Kwong PW, Leung LH: Stereotactic radiosurgery as a salvage treatment for locally persistent and recurrent nasopharyngeal carcinoma. Head Neck. 1999, 21: 620-626. 10.1002/(SICI)1097-0347(199910)21:7<620::AID-HED6>3.0.CO;2-Q.CrossRefPubMed Chua DT, Sham JS, Hung KN, Kwong DL, Kwong PW, Leung LH: Stereotactic radiosurgery as a salvage treatment for locally persistent and recurrent nasopharyngeal carcinoma. Head Neck. 1999, 21: 620-626. 10.1002/(SICI)1097-0347(199910)21:7<620::AID-HED6>3.0.CO;2-Q.CrossRefPubMed
12.
go back to reference Chua DT, Sham JS, Kwong PW, Hung KN, Leung LH: Linear accelerator-based stereotactic radiosurgery for limited, locally persistent, and recurrent nasopharyngeal carcinoma: efficacy and complications. Int J Radiat Oncol Biol Phys. 2003, 56: 177-183.CrossRefPubMed Chua DT, Sham JS, Kwong PW, Hung KN, Leung LH: Linear accelerator-based stereotactic radiosurgery for limited, locally persistent, and recurrent nasopharyngeal carcinoma: efficacy and complications. Int J Radiat Oncol Biol Phys. 2003, 56: 177-183.CrossRefPubMed
13.
go back to reference Chua DT, Sham JST, Hung KN, Leung LHT, Au GKH: Predictive factors of tumor control and survival after radiosurgery of local failures of nasopharyngeal carcinoma. Int J Radiat Oncolo Biol Phys. 2006, 66: 1415-1421. 10.1016/j.ijrobp.2006.07.1364.CrossRef Chua DT, Sham JST, Hung KN, Leung LHT, Au GKH: Predictive factors of tumor control and survival after radiosurgery of local failures of nasopharyngeal carcinoma. Int J Radiat Oncolo Biol Phys. 2006, 66: 1415-1421. 10.1016/j.ijrobp.2006.07.1364.CrossRef
14.
go back to reference American Joint Committee on Cancer: AJCC cancer staging handbook. 1998, Philadelphia: Lippincott Williams & Wilkins, 35-43. American Joint Committee on Cancer: AJCC cancer staging handbook. 1998, Philadelphia: Lippincott Williams & Wilkins, 35-43.
15.
go back to reference Chen HJ, Leung SW, Su CY: Linear accelerator based radiosurgery as a salvage treatment for skull base and intracranial invasion of recurrent nasopharyngeal carcinoma. Am J Clin Oncol. 2001, 24: 255-258. 10.1097/00000421-200106000-00009.CrossRefPubMed Chen HJ, Leung SW, Su CY: Linear accelerator based radiosurgery as a salvage treatment for skull base and intracranial invasion of recurrent nasopharyngeal carcinoma. Am J Clin Oncol. 2001, 24: 255-258. 10.1097/00000421-200106000-00009.CrossRefPubMed
16.
go back to reference O'Donnell HE, Plowman PN, Khaira MK, Alusi G: PET scanning and gamma knife radiosurgery in the early diagnosis and salvage "cure" of locally recurrent nasopharyngeal carcinoma. Br J Radiol. 2008, 81: 26-30. 10.1259/bjr/15812414.CrossRef O'Donnell HE, Plowman PN, Khaira MK, Alusi G: PET scanning and gamma knife radiosurgery in the early diagnosis and salvage "cure" of locally recurrent nasopharyngeal carcinoma. Br J Radiol. 2008, 81: 26-30. 10.1259/bjr/15812414.CrossRef
17.
go back to reference Kocher M, Voges J, Staar S, Treuer H, Sturm V, Mueller RP: Linear accelerator radiosurgery for recurrent malignant tumors of the skull base. Am J Clin Oncol. 1998, 21: 18-22. 10.1097/00000421-199802000-00004.CrossRefPubMed Kocher M, Voges J, Staar S, Treuer H, Sturm V, Mueller RP: Linear accelerator radiosurgery for recurrent malignant tumors of the skull base. Am J Clin Oncol. 1998, 21: 18-22. 10.1097/00000421-199802000-00004.CrossRefPubMed
18.
go back to reference Yu KH, Leung SF, Tung SY, et al: Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group. Head Neck. 2005, 27: 397-405. 10.1002/hed.20161.CrossRefPubMed Yu KH, Leung SF, Tung SY, et al: Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group. Head Neck. 2005, 27: 397-405. 10.1002/hed.20161.CrossRefPubMed
19.
go back to reference Chua DT, Wei W, Sham JS, Hung KW, Au GH: Stereotactic radiosurgery versus gold gain implantation in salvaging local failures of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2007, 69: 469-474.CrossRefPubMed Chua DT, Wei W, Sham JS, Hung KW, Au GH: Stereotactic radiosurgery versus gold gain implantation in salvaging local failures of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2007, 69: 469-474.CrossRefPubMed
20.
go back to reference Chang JT, See LC, Liao CT, Ng SH, Wang CH, Chen IH, Tsang NM, Tseng CK, Tang SG, Hong JH: Locally recurrent nasopharyngeal carcinoma. Radiother Oncol. 2000, 54: 135-142. 10.1016/S0167-8140(99)00177-2.CrossRefPubMed Chang JT, See LC, Liao CT, Ng SH, Wang CH, Chen IH, Tsang NM, Tseng CK, Tang SG, Hong JH: Locally recurrent nasopharyngeal carcinoma. Radiother Oncol. 2000, 54: 135-142. 10.1016/S0167-8140(99)00177-2.CrossRefPubMed
21.
go back to reference Leung TW, Tung SY, Sze WK, Sze WM, Wong VY, Wong CS, O SK: Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2000, 48: 1331-1338.CrossRefPubMed Leung TW, Tung SY, Sze WK, Sze WM, Wong VY, Wong CS, O SK: Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2000, 48: 1331-1338.CrossRefPubMed
Metadata
Title
Validation of a prognostic scoring system for locally recurrent nasopharyngeal carcinoma treated by stereotactic radiosurgery
Authors
Daniel TT Chua
Kwan-Ngai Hung
Victor Lee
Sherry CY Ng
Janice Tsang
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2009
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-9-131

Other articles of this Issue 1/2009

BMC Cancer 1/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine